NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
87 hedge funds and large institutions have $76.9M invested in Navidea Biopharmaceuticals Inc. in 2013 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 21 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
16% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 25
17% less call options, than puts
Call options by funds: $1.04M | Put options by funds: $1.26M
Holders
87
Holding in Top 10
1
Calls
$1.04M
Puts
$1.26M
Top Buyers
| 1 | +$6.42M | |
| 2 | +$3.52M | |
| 3 | +$1.66M | |
| 4 |
CCA
Catalyst Capital Advisors
Huntington,
New York
|
+$1.64M |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
+$1.44M |
Top Sellers
| 1 | -$4.63M | |
| 2 | -$330K | |
| 3 | -$307K | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$257K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$249K |